Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AT7519 |
Trade Name | |
Synonyms | AT7519M|AT-7519 |
Drug Descriptions |
AT7519 is an ATP competitive inhibitor of CDK1, CDK2, CDK4, CDK5, CDK6, and CDK9, which may induce cell cycle arrest and apoptosis in cancer cells (PMID: 19174555, PMID: 32802093, PMID: 32279103). |
DrugClasses | CDK1 Inhibitor 13 CDK2 Inhibitor 31 CDK4 Inhibitor 17 CDK4/6 Inhibitor 14 CDK5 Inhibitor 8 CDK6 Inhibitor 6 CDK9 Inhibitor 21 |
CAS Registry Number | 844442-38-2 |
NCIT ID | C64761 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AT7519 | AT7519 | 0 | 1 |